Press release:

Asia flow chemistry system heralds success for Syrris Syrris, a world leader in flow product innovation, is enjoying outstanding success with sales of Asia, its revolutionary range of advanced flow chemistry products. Sales of the modular Asia flow product have been hailed a triumph for the Company, as ever-increasing numbers of scientists around the world discover the benefits the system offers to the laboratory. Designed by chemists,
[more]

Press release:

GENTs Makes an Impression: Austrian Building Award Goes to Structural Design Tool For the first time, new types of complex load-bearing structures can now be both designed and calculated using a single computer programme. This has become possible thanks to the new software "GENTs", developed as part of a project sponsored by the Austrian Science Fund (FWF). The software combines evolutionary optimisation methods and computer-based calculation tools for the first time to
[more]

Press release:

EU Project ECONAV Helps Plan Eco-Friendly Trips with Comfort The European Commission is funding the project EcoNav – Ecological Aware Navigation – Usable Persuasive Trip Advisor for Reducing CO2 consumption, which is led by CURE – Center for Usability Research & Engineering, an independent Austrian research institute. In our highly globalized world, mobility and transport are becoming increasingly important. This has a strong environmental impact, in particular in urban areas.
[more]

Press release:

Syrris custom reactors – built for you Syrris is a world leader in modular laboratory scale chemistry systems – including the flexible Atlas and Globe ranges – and also offers a bespoke reactor design service to meet the most specialized requirements. Syrris is a world leader in modular laboratory scale chemistry systems – including the flexible Atlas and Globe ranges – and also offers a bespoke reactor
[more]

Press release:

High School Chemistry Teacher Says 10-minute-a-day Online Tutor Helps Chemistry Students Succeed A new online high school chemistry tutoring service offers help in short, convenient 10 minute videos lessons, created by a high school chemistry teacher. Indio, CA – It only takes 10 minutes a day for any high school student to learn chemistry, according to Melanie Fine, a high school chemistry teacher who created an economical online chemistry video tutor. “Any high
[more]

Press release:

Flavor and fragrance production with the Syrris Atlas Calorimeter IFF, a leading global creator of flavors and fragrances, uses the Syrris Atlas Calorimeter for flavor and fragrance development at its production plant in Benicarlo, Spain. IFF, a leading global creator of flavors and fragrances, uses the Syrris Atlas Calorimeter for flavor and fragrance development at its production plant in Benicarlo, Spain. Chemical process engineer Onofre Casanova explained: “We purchased
[more]

Press release:

Tecan’s Infinite® M1000 and a plate of live fish! Tecan’s Infinite® M1000 multimode microplate reader has enabled scientists in the Department of Cellular Biology and Anatomy at Georgia Health Sciences University (GHSU), USA, to develop a high throughput system for reporter-based drug screening assays in living zebrafish disease models1. Tecan’s Infinite® M1000 multimode microplate reader has enabled scientists in the Department of Cellular Biology and Anatomy at Georgia Health
[more]

Press release:

John C. Lin, VP at Pfizer to speak at Ocular Drug Discovery conference Feb 27-28, 2012 John C. Lin, Vice President of Experimental Medicine at Pfizer will give a featured presentation on “Anti-amyloid Beta in Age-related Macular Degeneration” at the 4th Ocular Diseases and Drug Discovery Conference taking place on February 27-28, 2012 in Las Vegas, NV. John C. Lin, Vice President of Experimental Medicine at Pfizer will give a featured presentation on “Anti-amyloid Beta in
[more]

Press release:

Henry F. Edelhauser to speak at Ocular Drug Discovery conference Feb 27-28, 2012 Las Vegas, NV Henry (Hank) F. Edelhauser, Professor of Research (Basic Science) Section at Emory will give a Keynote presentation at the 4th Ocular Diseases and Drug Discovery Conference (February 27-28, 2012 in Las Vegas, NV) Henry (Hank) F. Edelhauser, Professor of Research (Basic Science) Section at Emory will give a Keynote presentation on “Preservative Free or BAK Free Formulations, That is the
[more]

Press release:

CSO at Aerie Pharma to speak at Ocular Drug Discovery conference Feb 27-28, 2012 Las Vegas, Casey C. Kopczynski, Chief Scientific Officer at Aerie Pharmaceuticals will give a presentation on “Rho Kinase Inhibitors for Glaucoma” at the 4th Ocular Diseases and Drug Discovery Conference taking place on February 27-28, 2012 in Las Vegas, NV. Casey C. Kopczynski, Chief Scientific Officer at Aerie Pharmaceuticals will give a presentation on “Rho Kinase Inhibitors for Glaucoma” at the 4th
[more]

Press release:

Iain Dukes, VP, R&D at Amgen to speak at Oncology Partnering Conference – Feb 27-28, 2012, Iain Dukes, Vice President, External R&D at Amgen is a Panelist in “Panel Discussion: Trends in Oncology Drug Development” at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Panel Discussion: Trends in Oncology Drug Development Topics to be covered: • Oncology business opportunities for partnerships (who, what. why) • Trends in favorable deal structures
[more]

Press release:

John Herrmann at Eli Lilly to present at Oncology Partnering Conference – Feb 27-28, 2012, Las John Herrmann, Senior Director, Global External Research & Development, Oncology at Eli Lilly to give a Featured Presentation on “Partnering with Lilly Oncology: Bring Proof-of-Relevance or Go Lean-to-POC” at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Partnering with Lilly Oncology: Bring Proof-of-Relevance or Go Lean-to-POC Presentation will provide the audience
[more]

Press release:

Denis Patrick at Pfizer to present at Oncology Partnering Conference - Oct 27-28, 2012, Las Vegas Denis Patrick, Senior Director & Head, External R&D Innovation, Oncology Research Unit at Pfizer to give a Featured Presentation on “Antibody Drug Conjugation Technology: Past, Present and Future” at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Antibody Drug Conjugation Technology: Past, Present and Future The promise of Antibody Drug Conjugation
[more]

Press release:

Claude Gimmi at Boehringer to present at Oncology Partnering Conference – Feb 27-28, 2012, Las Vegas Claude Gimmi, Global Head, Business development and Licensing Oncology, Therapeutic Alliances and Strategic Partnerships at Boehringer-Ingelheim to give a Featured Presentation on “Sincerely, Yours – Partnering with Boehringer Ingelheim in Oncology” at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Sincerely, Yours – Partnering with Boehringer Ingelheim in Oncology The presentation
[more]

Press release:

Anne Altmeyer, Novartis to speak at Oncology Partnering Conference – Feb 27-28, 2012, Las Vegas Anne Altmeyer, Executive Director, Business Development & Licensing, Oncology, at Novartis is a Panelist in “Panel Discussion: Innovative Partnering & Licensing Strategies” at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Panel Discussion: Innovative Partnering & Licensing Strategies Topics to be covered: • What are the trends in licensing? • What are some of
[more]

Press release:

SVP at GlaxoSmithKline to speak at Immunotherapeutics Partnering conference Jan 2012, San Diego, CA Vincent G. Brichard, Senior Vice President and Head of the Immunotherapeutics Business Unit at GlaxoSmithKline Biologicals will give a keynote presentation on the “Development of Active Immunization against Cancer: The Example of MAGE-A3” at the Immunotherapeutics Partnering and Deal-making Conference to be held in San Diego, CA on January 30-31, 2012 by GTC. Dr. Brichard will present GSK’s progress in
[more]

Press release:

CEO at ImmusanT to speak at Immunotherapeutics Partnering conference Jan 30-31 2012, San Diego, CA Leslie J. Williams, President and CEO at ImmusanT will give a presentation on “ImmusanT’s Development of an Immunotherapeutic Vaccine for Celiac Disease” at the Immunotherapeutics Partnering and Deal-making Conference to be held in San Diego, CA on January 30-31, 2012 by GTC. Celiac Disease is an inherited autoimmune disease triggered by the consumption of foods containing gluten. The chronic
[more]

Press release:

Jeremy Barton VP at Pfizer to speak at Cancer Targets meeting, Feb 27-28, 2012, Las Vegas Jeremy Barton obtained his Batchelors degree in Physiological Sciences from Oxford University and then graduated from University College Hospital Medical School, London. After training in Internal Medicine he specialized in Clinical Oncology in the UK achieving Specialist status in this area. He is a member of the Royal College of Physicians (UK) and a Fellow of the Royal College of
[more]

Press release:

C. Glenn Begley VP at Amgen to speak at Cancer Targets meeting, Feb 27-28, 2012, Las Before joining Amgen, he had over 20 years clinical experience in medical oncology and hematology, and his personal research focused on translational clinical trials and regulation of hematopoietic cells. One of his early papers first identified the human growth factor, G-CSF. This was followed by studies defining CSF receptor expression and function in-vivo. He first identified the transcription factor SCL,
[more]

Press release:

The pharmaceutical industry is set to gather at GTC’s Biomarker Summit 2012 (March 15-16, 2012 in GTC is pleased to announce Biomarker Summit 2012 will be March 15-16 at the Paradise Point Resort in San Diego. Broken into four tracks, the Summit will include the 6th Biomarker Development Conference, 4th Oncology Biomarker Conference, Biomarkers & Diagnostics Conference and Biomarker Partnering & Deal-Making Conference. Offering delegates the choice to attend one track of the
[more]